THOMAS J DAVIS

Allopathic & Osteopathic Physicians|Family Medicine OAKDALE, LA NPI 1548320161

General Payments — all program years on this page

$1,725.00

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 125
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $224.48 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $224.4815

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $139.1210
Acerta Pharma LLC $37.092
Amgen Inc. $19.181
Lilly USA, LLC $15.291
ABBVIE INC. $13.801

By program year

Program yearAmountRecords
2018 $207.4213
2019 $396.9237
2020 $166.2911
2021 $162.8214
2022 $237.9615
2023 $329.1120
2024 $224.4815

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096601805 Novo Nordisk Inc $15.58 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096648746 Novo Nordisk Inc $19.12 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096652786 Novo Nordisk Inc $14.32 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096915742 Novo Nordisk Inc $12.36 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096974979 Novo Nordisk Inc $11.68 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097027126 Novo Nordisk Inc $17.80 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097140818 Novo Nordisk Inc $12.03 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097296755 Novo Nordisk Inc $10.71 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097556795 Novo Nordisk Inc $13.08 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097604618 Novo Nordisk Inc $12.44 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103610382 ABBVIE INC. $13.80 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104265283 AstraZeneca Pharmaceuticals LP $17.19 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104688744 AstraZeneca Pharmaceuticals LP $19.90 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117536990 Amgen Inc. $19.18 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135457459 Lilly USA, LLC $15.29 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.